New research centre for neurological disease

Artist impression of the new state of the art research facility for UCL

This article first appeared in issue 6 of Portico magazine, published November 2019.

Conditional planning permission has been granted to transform 256 Grays Inn Road, London, into a world-leading hub for dementia and neurological disease research. The state-of-the-art facility will house more than 500 research scientists, with a mission to create a collaborative, interdisciplinary environment that translates UCL’s research power into developing treatments for a range of neurological conditions. The building will be the hub of research activities and the operational headquarters of the UK Dementia Research Institute, and will house outpatient consulting, and an MRI suite for the UCLH National Hospital for Neurology and Neurosurgery.

Discover more about UCL Queen Square Institute of Neurology and the UK Dementia Research Institute.

This article first appeared in issue 6 of Portico magazine, published November 2019.

This article first appeared in issue 6 of Portico magazine, published November 2019.

Conditional planning permission has been granted to transform 256 Grays Inn Road, London, into a world-leading hub for dementia and neurological disease research. The state-of-the-art facility will house more than 500 research scientists, with a mission to create a collaborative, interdisciplinary environment that translates UCL’s research power into developing treatments for a range of neurological conditions. The building will be the hub of research activities and the operational headquarters of the UK Dementia Research Institute, and will house outpatient consulting, and an MRI suite for the UCLH National Hospital for Neurology and Neurosurgery.

Discover more about UCL Queen Square Institute of Neurology and the UK Dementia Research Institute.

This article first appeared in issue 6 of Portico magazine, published November 2019.

This article first appeared in issue 6 of Portico magazine, published November 2019.

Conditional planning permission has been granted to transform 256 Grays Inn Road, London, into a world-leading hub for dementia and neurological disease research. The state-of-the-art facility will house more than 500 research scientists, with a mission to create a collaborative, interdisciplinary environment that translates UCL’s research power into developing treatments for a range of neurological conditions. The building will be the hub of research activities and the operational headquarters of the UK Dementia Research Institute, and will house outpatient consulting, and an MRI suite for the UCLH National Hospital for Neurology and Neurosurgery.

Discover more about UCL Queen Square Institute of Neurology and the UK Dementia Research Institute.

This article first appeared in issue 6 of Portico magazine, published November 2019.